Insights On Drug Development

  1. A Positive GMP Experience: Replacing Functional Handoffs With Project-Based Execution 8/20/2026

    Explore strategies for creating a stronger GMP culture through effective quality practices, collaboration, training, and continuous improvement. Learn how positive compliance experiences can support operational excellence, reduce risk, and strengthen manufacturing performance.

  2. Small-Scale Prototyping with Scale in Mind: Building Drug Product Robustness Earlier 8/20/2026

    Learn how intentional small-scale development workflows can reduce scale-up risk by improving process understanding, strengthening formulation robustness, identifying critical quality attributes early, and creating a more predictable path from prototype to clinical manufacturing.

  3. SEDDS: Improving Oral Bioavailability Of Poorly Soluble Compounds 8/20/2026

    Nearly 90% of marketed drugs have poor water solubility. Learn how self-emulsifying drug delivery systems (SEDDS) resolve oral bioavailability failures across BCS Class II and IV compounds.

  4. Curia's Approach To Regulatory Compliance In Japan 8/20/2026

    Japan's pharmaceutical market demands J-DMF registration, Foreign Manufacturer Accreditation, and GMP compliance. Learn how experienced CDMO support simplifies PMDA submissions and accelerates your market entry.

  5. Maximizing Drug Formulation For First-In-Human Trials 8/17/2026

    Discover how integrated formulation, manufacturing, and clinical strategies can accelerate early drug development, reduce timelines, and optimize drug products for clinical success.

  6. Navigating An Uncertain Regulatory Environment For mRNA-Based Products 8/17/2026

    mRNA developers face a regulatory gap: as of 2024, neither FDA nor EMA has issued CMC-specific guidelines. Learn how early regulator engagement and CDMO partnerships reduce risk.

  7. Exploring 4 Patient-Centric Trends Shaping Today's Biopharma Landscape 8/17/2026

    Patient centricity is reshaping pharma drug development through supply chain resiliency, decentralized trials, and patient-friendly formulations. Learn what these shifts mean for your pipeline strategy.

  8. Ophthalmic Drug Delivery: Meeting Modern Challenges With A Next Generation Solution 8/17/2026

    Ophthalmic injectable packaging demands early strategic attention. Learn how silicone oil contamination, particulate limits, and dosing accuracy challenges can derail development programs and what it takes to stay compliant.

  9. Cracking Complexity: Leveraging Lessons Learned For Future Bispecific Development 8/14/2026

    The shift from static platforms to adaptive, knowledge-driven development helps biopharma teams manage BsAb complexity, accelerate analytical, purification, and formulation development, and improve IND readiness.

  10. Reducing Risks In Biologics Manufacturing Through Predictive Modeling And PAT 8/12/2026

    Complex biologics development increasingly relies on adaptive, knowledge-driven strategies combining platform methods, targeted customization, high-throughput experimentation, and prior knowledge to accelerate IND readiness.